BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17550310)

  • 1. The burden of "sticky" amyloid: typing challenges.
    Picken MM; Herrera GA
    Arch Pathol Lab Med; 2007 Jun; 131(6):850-1. PubMed ID: 17550310
    [No Abstract]   [Full Text] [Related]  

  • 2. IgG1 lambda light and heavy chain renal amyloidosis.
    Nasr SH; Colvin R; Markowitz GS
    Kidney Int; 2006 Jul; 70(1):7. PubMed ID: 16810284
    [No Abstract]   [Full Text] [Related]  

  • 3. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
    Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
    Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid typing using antisera to prototype fibril proteins. A brief note.
    Linke RP
    Mech Ageing Dev; 1980; 14(1-2):187-90. PubMed ID: 6782378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemical classification of amyloid. Correlation with different clinical types of amyloidosis.
    Husby G
    Scand J Rheumatol; 1980; 9(1):60-4. PubMed ID: 6769151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
    Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
    Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin-related (AL) amyloidosis.
    Husby G
    Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral intratarsal dystrophic calcification and ossification in localized immunoglobulin light chain amyloid.
    Charles NC; Dunbar KE; Lisman RD
    Can J Ophthalmol; 2018 Apr; 53(2):e67-e69. PubMed ID: 29631846
    [No Abstract]   [Full Text] [Related]  

  • 9. IgD amyloid in IgD-lambda monoclonal conjunctival amyloidosis. A case report.
    Schaldenbrand JD; Keren DF
    Arch Pathol Lab Med; 1983 Dec; 107(12):626-8. PubMed ID: 6416220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin heavy chain can be amyloidogenic: morphologic characterization including immunoelectron microscopy.
    Mai HL; Sheikh-Hamad D; Herrera GA; Gu X; Truong LD
    Am J Surg Pathol; 2003 Apr; 27(4):541-5. PubMed ID: 12657941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of plasma cell clonality in localized AL amyloidosis.
    Setoguchi M; Hoshii Y; Kawano H; Ishihara T
    Amyloid; 2000 Mar; 7(1):41-5. PubMed ID: 10842704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of different amyloids with immunological techniques.
    Chastonay P; Hurlimann J
    Pathol Res Pract; 1986 Dec; 181(6):657-63. PubMed ID: 3104892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril in primary amyloidosis.
    Block PJ; Skinner M; Benson MD; Cohen AS
    Arthritis Rheum; 1976; 19(4):755-9. PubMed ID: 821491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
    Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
    Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that amyloidogenic light chains undergo antigen-driven selection.
    Perfetti V; Ubbiali P; Vignarelli MC; Diegoli M; Fasani R; Stoppini M; Lisa A; Mangione P; Obici L; Arbustini E; Merlini G
    Blood; 1998 Apr; 91(8):2948-54. PubMed ID: 9531605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and clinical classification of amyloidosis 1985.
    Husby G; Sletten K
    Scand J Immunol; 1986 Mar; 23(3):253-65. PubMed ID: 3082001
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoglobulin heavy-chain-associated amyloidosis.
    Eulitz M; Weiss DT; Solomon A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-light-chain immunoglobulin amyloidosis: time to expand or refine the spectrum to include light+heavy chain amyloidosis?
    Picken MM
    Kidney Int; 2013 Mar; 83(3):353-6. PubMed ID: 23446254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of apolipoprotein-E in fibrillogenesis.
    Gallo G; Wisniewski T; Choi-Miura NH; Ghiso J; Frangione B
    Am J Pathol; 1994 Sep; 145(3):526-30. PubMed ID: 8080036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.